United States· US:70518-3826_3f686042-02c3-8a78-e063-6294a90a7f56
Celecoxib
A celecoxib product containing celecoxib, registered in United States by REMEDYREPACK INC.. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Celecoxib is registered in 13 of 19 countries.
Countries holding a registration under ATC M01AH01 (celecoxib), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Celecoxib · ATC M01AH01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of celecoxib costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.40 in Italy to $1.31 in Switzerland — a ×3.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Celecoxib · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.31
- ES Spain$0.85
- IT Italy$0.40
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Celecoxib
- Manufacturer
- REMEDYREPACK INC.
- Country
- United States (US)
- ATC code
- M01AH01
- ATC class
- Celecoxib
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 2
- ndc11705183826090 CAPSULE in 1 BOTTLE, PLASTIC (70518-3826-0)
- ndc11705183826260 CAPSULE in 1 BOTTLE, PLASTIC (70518-3826-2)
Regulatory notes
Interactions
778 interactions on record for celecoxib.
Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Celecoxib · interactions on record
778 records
- 36 severe
- 349 moderate
- 4 minor
- 360 info
Most severe, free to view
- EliglustatA16AX10severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CimetidineA02BA01moderate
29 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Celecoxib in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaACLEXAKrka, d.d., Novo mesto, Novo mesto
- United KingdomCelebrex 100mg capsulesStephar (U.K.) Ltd
- CanadaAG-CELECOXIBANGITA PHARMA INC.
- FranceCELEBREX 100 mg, géluleVIATRIS UP
- BelgiumCelebrex 100 mgViatris Healthcare
- NetherlandsBixocel 100 mg, capsules, hardSynthon B.V.
- FinlandCelebraViatris Healthcare Limited
- SwitzerlandCelebrex
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Celebrex, Celecoxib Ratiopharm
- Belgium · Celebrex, Celecoxib Ab
- Bulgaria · Аклекса, Дефинакс
- Cyprus · Celebrex, Celecoxib Accord
- Czechia · Aclexa, Celebrex
- Germany · Celebrex, Celecaxiro
- Denmark · Celebra, Celecoxib Accord
- Estonia · Aclexa, Celebrex
- Spain · Artilog, Axatal
- Finland · Celebra, Celecoxib Krka
- France · Celebrex, Celecoxib Arrow Lab
- United Kingdom (Northern Ireland) · Celebrex, Celecoxib
- Greece · Celebrex
- Croatia · Aclexa, Celixib
- Hungary · Aclexa, Celebrex
- Ireland · Celebrex, Celecoxib Accord Healthcare Ireland
- Iceland · Celebra, Celecoxib Actavis
- Italy · Celartrox, Celebrex
- Lithuania · Aclexa, Celecoxib Accord
- Luxembourg · Celebrex, Celecoxib Eg
- Latvia · Celebrex, Celecoxib Inteli
- Malta · Aclexa, Celebrex
- Netherlands · Bixocel, Celebrex
- Norway · Celebra, Celecoxib Accord
- Poland · Aclexa, Celebrex
- Portugal · Celebrex, Celecoxib Alter
- Romania · Aclexa, Capsule Teva
- Sweden · Celebra, Celecoxib Accord
- Slovenia · Aclexa, Celebrex
- Slovakia · Aclexa, Celebrex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cc27259c-2ef3-4664-b6ae-83d009e26334 GET /v1/drugs/cc27259c-2ef3-4664-b6ae-83d009e26334?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "JCX84Q7J1L",
"rxcui": "140587",
"inchikey": "RZEKVGVHFLEQIL-UHFFFAOYSA-N",
"display_name": "CELECOXIB",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 2
},
"spl_meta": {
"27f17ae7-939b-402e-9498-3b6611104089": {
"match": "brand_token",
"title": "CELECOXIB CAPSULE [REMEDYREPACK INC.]",
"spl_version": "7",
"published_date": "2026-05-28"
}
},
"productid": "70518-3826_3f686042-02c3-8a78-e063-6294a90a7f56",
"productndc": "70518-3826",
"dosage_form": "CAPSULE",
"orange_book": {
"appl_no": "210071",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "50MG",
"product_no": "001",
"approval_date": "Jan 23, 2018"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "100MG",
"product_no": "002",
"approval_date": "Jan 23, 2018"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "200MG",
"product_no": "003",
"approval_date": "Jan 23, 2018"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "CELECOXIB",
"shortage_reason": "Celecoxib Capsule",
"shortage_status": "current",
"proprietary_name": "Celecoxib",
"active_ingred_unit": "mg/1",
"application_number": "ANDA210071",
"marketing_category": "ANDA",
"nonproprietary_name": "Celecoxib",
"start_marketing_date": "20230812",
"active_numerator_strength": "100"
}See everything about celecoxib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.